Overview

Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and efficacy of open-label fluoxetine for three months among patients with pulmonary arterial hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Center for Research Resources (NCRR)
Treatments:
Fluoxetine